Squarepoint
ZURA icon

Squarepoint’s Zura Bio ZURA Stock Holding History

Squarepoint’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Buy
44,939
+11,138
+33% +$67.3K ﹤0.01% 3794
2025
Q4 		$177K Buy
33,801
+8,680
+35% +$34.3K ﹤0.01% 3906
2025
Q3 		$109K Buy
+25,121
New +$45.2K ﹤0.01% 4096
2025
Q2 		– Sell
-15,238
Closed -$19.7K – 5165
2025
Q1 		$19.7K Sell
15,238
-8,134
-35% -$12.8K ﹤0.01% 4440
2024
Q4 		$58.4K Sell
23,372
-22,083
-49% -$78.7K ﹤0.01% 4815
2024
Q3 		$185K Buy
+45,455
New +$170K ﹤0.01% 3715

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Squarepoint's ZURA Position: Q1 2026 in Review

Squarepoint increased its Zura Bio (ZURA) stake by 33% in Q1 2026, buying an estimated $67.3K and bringing the position to 44,939 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #3794.

Squarepoint first reported a position in ZURA in Q3 2024 and has held it in 6 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Squarepoint held 44,939 shares of Zura Bio worth $267K as of Q1 2026.
  • Squarepoint bought 11,138 Zura Bio shares in Q1 2026, an estimated $67.3K.
  • Zura Bio made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3794 holding.
  • Squarepoint first reported a position in Zura Bio in Q3 2024 and has held it in 6 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.